Barr Pharmaceuticals Inc. announced that its subsidiary, Barr Laboratories Inc., has received final approval from the FDA for its Abbreviated New Drug Application (ANDA) to manufacture and market a generic version of Yasmin (drospirenone and ethinyl estradiol). Yasmin is an oral contraceptive product manufactured and marketed by Bayer Schering Pharma AG.

Dilon Technologies has received CE Marking for its Dilon 6800 gamma camera. The high-resolution gamma camera enables molecular imaging of the breast and other small organs for early cancer detection. It performs breast-specific gamma imaging, a technique that images the metabolic activity of breast lesions through radiotracer uptake.

 St. Jude Medical Inc. has launched the TigerWire steerable guidewire in the U.S. A guidewire is used by physicians to move a catheter through the arteries. It enables doctors to diagnose the severity of disease and deliver treatments such as stents to open blockages and restore blood flow.

Progenics Pharmaceuticals Inc. and Wyeth Pharmaceuticals Inc. have received FDA approval for their Relistor, a treatment for opioid-induced constipation. Relistor (methylnaltrexone bromide) is a subcutaneous injection for patients with advanced illness who receive palliative care and who have not responded to laxative therapy.